Daniel Carlat, MD

4 Rationalizations for Cannabis Use—And How to Respond

May 26, 2025

Daniel Carlat, MD

4 Keys to Discharging Patients Who Refuse To Leave

May 25, 2025

Daniel Carlat, MD

You Can Be Neurodivergent. And Still Need Care.

When Neurodivergence Becomes a Rejection of Treatment, Patients Lose

May 24, 2025

Daniel Carlat, MD

At Carlat Publishing, we regularly debate trends in psychiatry—and neurodivergence is one of today’s most charged topics.
Let’s call it opinion divergence: Some on our team feel that the DSM-5 term “autism spectrum disorder” is politically insensitive. Others see it as clinically essential.

The Strange Side of Antidepressants

Fun facts from the upcoming Medication Fact Book, 8th Edition

May 23, 2025

Daniel Carlat, MD

Benzos: Misunderstood, Misused — but Sometimes Just Right.

May 22, 2025

Daniel Carlat, MD

"The only thing that works for me is Xanax." "Can I get a 3-month script for Klonopin? My last doc didn't mind."
We’ve all heard versions of these.

FDA Clears First Alzheimer's Blood Test—What's Actually New Here?

May 21, 2025

Daniel Carlat, MD

This week, the FDA cleared the first blood test for Alzheimer’s disease: the Lumipulse G pTau217/β-Amyloid 1-42 Plasma Ratio.It sounds like a big step forward. Maybe it will prove to be one. But after 22 years of Carlat Report coverage of overhyped tests and treatments, I’ve learned to pause before celebrating “firsts.”

Choosing ADHD Meds: A 3 Minute Overview

May 21, 2025

Daniel Carlat, MD

ADHD pharmacology can feel overwhelming. Dozens of formulations. Conflicting data. High stakes for outcomes—and side effects. Each chapter of our Medication Fact Book starts with general tips, and I’m revising the ADHD section for our 8th edition.

CLINICAL UPDATE

Social Anxiety Disorder: Diagnosis and Treatment

January 10, 2025

Daniel Carlat, MD

Daniel Carlat, MD. Medical Director of Inpatient Psychiatry/Chairman of Psychiatry at Melrose Wakefield Healthcare. Publisher, Carlat Publishing.
Dr. Carlat has no financial relationships with companies related to this material.

Dr. Carlat provides an array of treatments for social anxiety disorder, from SSRIs to psychotherapy,

CLINICAL UPDATE

Treating Bipolar Disorder With Interpersonal and Social Rhythm Therapy

December 18, 2024

Daniel Carlat, MD

Daniel Carlat, MD. Vice Chair, Community and Public Sector Psychiatry, Tufts University School of Medicine. Publisher, Carlat Publishing.
Dr. Carlat has no financial relationships with companies related to this material.

Meds are essential for treating bipolar disorder, but recovery requires more. Interpersonal and Social Rhythm Therapy (IPSRT) empowers patients to stabilize daily routines and strengthen relationships. Here's how it works.

Clinical Guidance